Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05440448 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Patch-free Occlusion Therapy

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updated
    • Eligibility criteria shortened, about 3 words
    v6
  2. Primary completion date: Mar 2027 to Jan 31, 2028v5 Show 4 more changesShow less
    • Start date: Jun 12, 2023 to Apr 22, 2024
    • Study completion date: Dec 2027 to Jun 30, 2028
    • Site contact updated
    • Collaborators expanded, about 4 words
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 2023 to Jun 12, 2023
    v4
  4. Eligibility criteria expanded, about 3 wordsv3
  5. Eligibility criteria revisedv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to determine whether a patch-free occlusion therapy leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to the treatment.
Trial Details
NCT Number NCT05440448
Lead Sponsor Retina Foundation of the Southwest
Collaborators: National Eye Institute (NEI)
Conditions
(from sponsor)		 Amblyopia
Related terms Amblyopia
Enrollment 68 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov